薬剤比較
Exenatide vs Repaglinide
Exenatide vs Repaglinide: GLP-1 injection vs oral meglitinide for type 2 diabetes. Compare efficacy, weight effects, hypo risk, dosing, and suitability.
このページには比較できる項目がありません。
臨床的背景
This comparison arises for type 2 diabetes patients needing add-on therapy after metformin, weighing injectable GLP-1 benefits against oral meglitinide convenience.
結論
Exenatide may suit those prioritizing weight loss and CV benefits, while Repaglinide fits patients preferring oral, flexible dosing without injections.
すべての薬剤比較